49
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Cutaneous necrobiotic conditions associated with rheumatoid arthritis: important extra-articular involvement

Pages 617-622 | Received 19 Jul 2012, Accepted 11 Sep 2012, Published online: 02 Jan 2014

REFERENCES

  • Sayah A, English JC III. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005;53: 191–209.
  • Douglas KM, Ladoyanni E, Trehame GJ, Hale ED, Erb N, Kitas GD. Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions. Ann Rheum Dis. 2006;65 :1341–5.
  • Ergun T, Inane N, Tuney D, Kotiloglu EK, Seckin D, Tetik C, et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int J Dermatol. 2008;47:894–902.
  • Yamamoto T. Cutaneous manifestations associated with rheu-matoid arthritis. Rheumatol Int. 2009;29:979–88.
  • Chu P, Connolly K, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol. 1994;130: 1278–83.
  • Sangueza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Griffin JE, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002;47:251–7.
  • Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol. 2003;30:1–10.
  • Lynch JM, Barrett TL. Collagenolytic (necrobiotic) granulomas: part II-the 'red' granulomas. J Cutan Pathol. 2004;31:409–18.
  • Garcia-Patos V. Rheumatoid nodule. Semin Cutan Med Surg. 2007;26:100–7.
  • Highton J, Hessian PA, Stamp L. The rheumatoid nodule: peripheral or central to rheumatoid arthritis? Rheumatology. 2007;46:1385–7.
  • Yamamoto T, Matsunaga T, Yokozeki H, Katayama I, Nishioka K. Inducible nitric oxide synthase expression on a rheumatoid nodule and in rheumatoid papules. Br J Dermatol. 1998;139:739–40.
  • Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al. Absence of a classically activated macro-phage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009;60:966–75.
  • Kennedy A, Fearon U, Veale DJ, Godson C. Macrophages in synovial inflammation. Front Immunol. 2011;2:52.
  • Ziff M. The rheumatoid nodule. Arthritis Rheum. 1990;33:761–7.
  • Wikaningrum R, Highton J, Parker A, Coleman M, Hessian PA, Roberts-Thomson PJ, et al. Pathogenic mechanisms in the rheu-matoid nodule: comparison of proinflammatory cytokine pro-duction and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum. 1998;41:1783–97.
  • Hessian PA, Highton J, Kean A, Sun CK, Chin M. Cytokine profile of the rheumatoid nodule suggests that it is a 'Th 1 gran-loma. Arthritis Rheum. 2003;48: 334–8.
  • Stamp LK, Easson A, Lehnigk U, Highton J, Hessian PA. Dif-ferent T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in the rheumatoid nodules. Arthritis Rheum. 2008;58: 1601–8.
  • Brennan FM, Browne KA, Green PA, Jaspar JM, Maim RN, Feldmann M. Reduction of serum marix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients fol-lowing anti-tumour necrosis factor-alpha (cA2) therapy. Br J Rheumatol. 1997;36:643–50.
  • Catrina AT, Lampa J, Emestam S, af Klint E, Bratt J, Klareskog L, et al. Anti-tumour necrosis factor (TNF)-a therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology. 2002;41: 484–9.
  • Katrib A, Smith MD, Ahern MJ, Slavotinek J, Stafford L, Cuello C, et al. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission. J Rheumatol. 2003;30:10–21.
  • Dyckman CJ, Galens GJ, Good AE. Linear subcutaneous bands in rheumatoid arthritis: an unusual form of rheumatoid granuloma. Ann Intern Med. 1965;63:134–40.
  • Betlloch I, Moragon M, Jorda E, Jimenez A, Ramon D, Verde-guer JM. Linear rheumatoid nodule. Int J Dermatol. 1988;27: 645–6.
  • Segal R, Caspi D, Tishler M, Fishel B, Yaron M. Accelerated nodulosis and vasculitis during methotrexate therapy for rheu-matoid arthritis. Arthritis Rheum. 1988;31:1182–5.
  • Kerstens PJ, Boerbooms AM, Jeurissen ME, Fast JH, Assmann KJ, van de Putte LB. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol. 1992;19:867–71.
  • Falcini F, Taccetti G, Emini M, Trapani S, Calzolari A, Franchi A, et al. Methotrexate-associated appearance and rapid progression of rheumatoid nodules in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:175–8.
  • Matsushita I, Uzuki M, Matsuno H, Sugiyama E, Kimura T. Rheumatoid nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. Mod Rheumatol. 2006;16:401–3.
  • Cronstein BN, Dwight N, Ostad E. The anti-inflammatory mechanisms of methotrexate. J Clin Invest. 1993;92:2675–82.
  • Merrill JT, Shen C, Schreibman D, Coffey D, Zakharenko 0, Fisher R, et al. Adenosine Al receptor promotion of multinu-cleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum. 1997;40: 1308–15.
  • Kekow J, Welte T, Kellner U, Pap T. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum. 2002;46:843–4.
  • Scrivo R, Spadaro A, Iagnocco A, Valesini G. Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol. 2007;25:117.
  • Cunnane G, Warnock M, Fye K, Daikh DI. Accerelated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002;47:445–9.
  • Baeten D, de Keyser F, Veys EM, Theate Y, Houssaiau FA, Durez P. Tumor necrosis factor a independent disease mecha-nisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann Rheum Dis. 2004;63:489–93.
  • Smith ML, Jorizzo JL, Semble E, Arrington JH, White WL. Rheumatoid papules: lesions showing features of vasculitis and palisading granuloma. J Am Acad Dermatol. 1989;20:348–52.
  • Higaki Y, Yamashita H, Sato K, Higaki M, Kawashima M. Rheumatoid papules: a report on four patients with histopatho-logic analysis. J Am Acad Dermatol. 1993;28:406–11.
  • Goerttler E, Kutzner H, Peter HH, Requena L. Methotrexate-induced popular eruption in patients with rheumatic diseases: a distinct adverse cutaneous reaction produced by methotrexate in patients with collagen vascular diseases. J Am Acad Dermatol. 1999;40:702–7.
  • Stephenson SR, Campbell SM, Drew GS, Magro CM. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab. J Cutan Pathol. 2011;38:644–8.
  • Appleton MAC, Ismail SM. Ulcerating rheumatoid nodule of the vulva. J Clin Pathol. 1996;49:85–7.
  • Horn RT, Goette DK. Perforating rheumatoid nodule. Arch Dermatol. 1982;118:696–7.
  • Seitz CS, Berens N, Bröcker EB, Trautmann A. Leg ulceration in rheumatoid arthritis-an underreported multicausal complication with considerable morbidity: analysis of thirty-six patients and review of the literature. Dermatology. 2010;220:268–73.
  • Jorizzo JL, Olansky AJ, Stanley RJ. Superficial ulcerating nec-robiosis in rheumatoid arthritis: a variant of the necrobiosis lipoidica-rheumatoid nodule spectrum? Arch Dermatol. 1982;118: 255–9.
  • Chen S-Y, Kamatani N, Kashiwazaki S. Multiple extra-articular synovial cyst formation: case report and review of the literature. Ann Rheum Dis. 1998;57:169–71.
  • Kirino Y, Ihata A, Shizukuishi K, Hama M, Takase K, Suda A, et al. Multiple extra-articular synovial cysts complicated with rheumatoid arthritis. Mod Rheumatol. 2009;19:563–6.
  • Barzilai A, Huszar M, Shpiro D, Nass D, Trau H. Pseudorheu-matoid nodules in adults: a juxta-articular form of nodular granuloma annulare. Am J Dermatopathol. 2005;27:1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.